http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
-
Exelixis (EXEL) and Aurigene Announce Promising Preclinical Data to Be Presented at ENA Symposium Support Clinical Development of Novel CDK7 Inhibitor
-
Exelixis and Aurigene Announce That Promising Preclinical Data to Be Presented at the ENA Symposium Support the Clinical Development of a Novel CDK7 Inhibitor
-
Global Response Aid and Dr. Reddy's Laboratories (RDY) Announces Avigan Shows Promising Results in Treatment of COVID Patients in Japan
-
Avigan® Shows Promising Results in Treatment of COVID Patients in Japan
-
Bristol-Myers Squibb (BMY) Announces Settlement of U.S. Patent Litigation for REVLIMID With Dr. Reddy’s (RDY)
-
Exelixis and Aurigene Enter Into Exclusive Collaboration, Option and License Agreement to Discover and Develop Novel Therapies for Cancer
-
UPDATE: Horizon Pharma (HZNP) Says District Court Upheld VIMOVO Patents
-
CytoSorbents Announces CytoSorb® Partnership with Dr. Reddy's Laboratories
-
Trading Radar for 7/26: Apple (AAPL), McDonald's (MCD), 3M (MMM), Caterpillar (CAT), Verizon (VZ), [Conference Call] Under Armour (UA) Report
-
SHAREHOLDER NOTICE: Goldberg Law PC Announces an Investigation of Claims against Dr. Reddy’s Laboratories Ltd. and Strongly Encourages Investors to Contact the Firm
-
Dr. Reddy’s Laboratories to Acquire Select Portfolio of the Established Products Business of UCB in India

